BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lim CT, Tan KW, Wu M, Ulferts R, Armstrong LA, Ozono E, Drury LS, Milligan JC, Zeisner TU, Zeng J, Weissmann F, Canal B, Bineva-Todd G, Howell M, O'Reilly N, Beale R, Kulathu Y, Labib K, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease. Biochem J 2021;478:2517-31. [PMID: 34198325 DOI: 10.1042/BCJ20210244] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao H, Dai R, Su R. Computer-aided drug design for the pain-like protease (PL(pro)) inhibitors against SARS-CoV-2. Biomed Pharmacother 2023;159:114247. [PMID: 36689835 DOI: 10.1016/j.biopha.2023.114247] [Reference Citation Analysis]
2 Alaofi AL, Shahid M, Raish M, Ansari MA, Syed R, Kalam MA. Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro. Molecules 2022;27:7553. [DOI: 10.3390/molecules27217553] [Reference Citation Analysis]
3 Gustavo Fernando Mercaldi, Eduardo Henrique Salviano Bezerra, Fernanda Aparecida Heleno Batista, Celisa Caldana Costa Tonoli, Adriana Santos Soprano, Jacqueline Farinha Shimizu, Alice Nagai, Jaqueline Cristina da Silva, Helder Veras Ribeiro Filho, Jéssica do Nascimento Faria, Marcos Guilherme da Cunha, Ana Carolina Mattos Zeri, Andrey Fabricio Ziem Nascimento, José Luiz Proenca-Modena, Marcio Chaim Bajgelman, Silvana Aparecida Rocco, Paulo Sérgio Lopes-de-Oliveira, Artur Torres Cordeiro, Marjorie Bruder, Rafael Elias Marques, Mauricio Luis Sforça, Kleber Gomes Franchini, Celso Eduardo Benedetti, Ana Carolina Migliorini Figueira, Daniela Barretto Barbosa Trivella. Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor. Sci Rep 2022;12:18500. [PMID: 36323732 DOI: 10.1038/s41598-022-22576-4] [Reference Citation Analysis]
4 Wang T, Li C, Wang M, Zhang J, Zheng Q, Liang L, Chu G, Tian X, Deng H, He W, Liu L, Li J. Expedient Synthesis of Ubiquitin‐like Protein ISG15 Tools through Chemo‐Enzymatic Ligation Catalyzed by a Viral Protease Lb pro. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202206205] [Reference Citation Analysis]
5 Walters K, Sajek MP, Issaian A, Baldwin A, Harrison E, Murphy E, Daniels M, Haines J, Hansen K, D’alessandro A, Mukherjee N. Small molecule inhibition of multiple RNA binding proteins underlies Musashi-2 independent phenotypes.. [DOI: 10.1101/2022.09.20.508735] [Reference Citation Analysis]
6 Gonzalez-rodriguez E, Zol-hanlon M, Bineva-todd G, Marchesi A, Skehel M, Mahoney KE, Roustan C, Borg A, Di Vagno L, Kjaer S, Wrobel AG, Benton DJ, Nawrath P, Flitsch SL, Joshi D, González-ramírez AM, Wilkinson KA, Wilkinson RJ, Hurtado-guerrero R, Malaker SA, Schumann B. O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Contribute to the Mutational Trajectory in Variants of Concern.. [DOI: 10.1101/2022.09.15.508093] [Reference Citation Analysis]
7 Manan A, Pirzada RH, Haseeb M, Choi S. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach. IJMS 2022;23:10716. [DOI: 10.3390/ijms231810716] [Reference Citation Analysis]
8 Hu Q, Xiong Y, Zhu GH, Zhang YN, Zhang YW, Huang P, Ge GB. The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19. MedComm (2020) 2022;3:e151. [PMID: 35845352 DOI: 10.1002/mco2.151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Srinivasan V, Brognaro H, Prabhu PR, de Souza EE, Günther S, Reinke PYA, Lane TJ, Ginn H, Han H, Ewert W, Sprenger J, Koua FHM, Falke S, Werner N, Andaleeb H, Ullah N, Franca BA, Wang M, Barra ALC, Perbandt M, Schwinzer M, Schmidt C, Brings L, Lorenzen K, Schubert R, Machado RRG, Candido ED, Oliveira DBL, Durigon EL, Niebling S, Garcia AS, Yefanov O, Lieske J, Gelisio L, Domaracky M, Middendorf P, Groessler M, Trost F, Galchenkova M, Mashhour AR, Saouane S, Hakanpää J, Wolf M, Alai MG, Turk D, Pearson AR, Chapman HN, Hinrichs W, Wrenger C, Meents A, Betzel C. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Commun Biol 2022;5:805. [PMID: 35953531 DOI: 10.1038/s42003-022-03737-7] [Reference Citation Analysis]
10 Rieder AS, Deniz BF, Netto CA, Wyse ATS. A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease. Neurotox Res 2022. [PMID: 35917086 DOI: 10.1007/s12640-022-00542-2] [Reference Citation Analysis]
11 Lee Y, Jeon YJ. Drugs targeting the viral enzymes of SARS-CoV-2. Med Biol Sci Eng 2022;5:47-51. [DOI: 10.30579/mbse.2022.5.2.47] [Reference Citation Analysis]
12 Azali MA, Mohamed S, Harun A, Hussain FA, Shamsuddin S, Johan MF. Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review. J Genet Eng Biotechnol 2022;20:98. [PMID: 35792966 DOI: 10.1186/s43141-022-00368-7] [Reference Citation Analysis]
13 Tan H, Hu Y, Jadhav P, Tan B, Wang J. Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease. J Med Chem 2022. [PMID: 35620927 DOI: 10.1021/acs.jmedchem.2c00303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
14 Calleja DJ, Lessene G, Komander D. Inhibitors of SARS-CoV-2 PLpro. Front Chem 2022;10:876212. [DOI: 10.3389/fchem.2022.876212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Jiang H, Yang P, Zhang J. Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone. Front Chem 2022;10:822785. [DOI: 10.3389/fchem.2022.822785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Lv Z, Cano KE, Jia L, Drag M, Huang TT, Olsen SK. Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development. Front Chem 2022;9:819165. [DOI: 10.3389/fchem.2021.819165] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
17 Ma C, Wang J. Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.1c00240] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
18 Narayanan A, Toner SA, Jose J. Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases. Biochem Soc Trans 2022:BST20211180. [PMID: 35015073 DOI: 10.1042/BST20211180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Guo D, Yao C, Wei W, Zhang J, Bi Q, Li J, Khan I, Bauer R. Traditional Chinese medicines against COVID-19: A global overview. World J Tradit Chin Med 2022;8:279. [DOI: 10.4103/2311-8571.353502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Lange SM, Armstrong LA, Kulathu Y. Deubiquitinases: From mechanisms to their inhibition by small molecules. Mol Cell 2021:S1097-2765(21)00947-3. [PMID: 34813758 DOI: 10.1016/j.molcel.2021.10.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
21 Ma C, Wang J. Validation and invalidation of SARS-CoV-2 papain-like protease inhibitors.. [DOI: 10.1101/2021.11.04.467342] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Españo E, Kim J, Lee K, Kim JK. Phytochemicals for the treatment of COVID-19. J Microbiol 2021;59:959-77. [PMID: 34724178 DOI: 10.1007/s12275-021-1467-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Canal B, Fujisawa R, McClure AW, Deegan TD, Wu M, Ulferts R, Weissmann F, Drury LS, Bertolin AP, Zeng J, Beale R, Howell M, Labib K, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochem J 2021;478:2465-79. [PMID: 34198324 DOI: 10.1042/BCJ20210199] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
24 Canal B, McClure AW, Curran JF, Wu M, Ulferts R, Weissmann F, Zeng J, Bertolin AP, Milligan JC, Basu S, Drury LS, Deegan TD, Fujisawa R, Roberts EL, Basier C, Labib K, Beale R, Howell M, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease. Biochem J 2021;478:2445-64. [PMID: 34198326 DOI: 10.1042/BCJ20210198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
25 Hay RT. An all-out assault on SARS-CoV-2 replication. Biochem J 2021;478:2399-403. [PMID: 34198321 DOI: 10.1042/BCJ20210256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Milligan JC, Zeisner TU, Papageorgiou G, Joshi D, Soudy C, Ulferts R, Wu M, Lim CT, Tan KW, Weissmann F, Canal B, Fujisawa R, Deegan T, Nagaraj H, Bineva-Todd G, Basier C, Curran JF, Howell M, Beale R, Labib K, O'Reilly N, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease. Biochem J 2021;478:2499-515. [PMID: 34198327 DOI: 10.1042/BCJ20210197] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
27 Bertolin AP, Weissmann F, Zeng J, Posse V, Milligan JC, Canal B, Ulferts R, Wu M, Drury LS, Howell M, Beale R, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase. Biochem J 2021;478:2425-43. [PMID: 34198323 DOI: 10.1042/BCJ20210200] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
28 Zeng J, Weissmann F, Bertolin AP, Posse V, Canal B, Ulferts R, Wu M, Harvey R, Hussain S, Milligan JC, Roustan C, Borg A, McCoy L, Drury LS, Kjaer S, McCauley J, Howell M, Beale R, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase. Biochem J 2021;478:2405-23. [PMID: 34198322 DOI: 10.1042/BCJ20210201] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]